Horia Bumbea

Spitalul Universitar de Urgenta, Bucharest, .

E-mail: trimite un mesaj.

Pagina web personala: https://sites.google.com/site/horiabumbea/

Nascut(a) in: 1968

Interese: hematologie, flowcitometrie

Details:
immunophenotyping on leukemias and lymphomas
CLL, epidemiology in Romania, registry, diagnosis and prognosis markers

Publicații selectate:

* Vladareanu AM, Popov V, Bumbea H, Onisai M, Ilea A, Dobrea C, Miulescu M., Splanchnic vein thrombosis, the onset manifestation in JAK positive Chronic Myeloproliferative Disorders Neoplasms, Journal of Medicine and Life, Jan-Mar;4(1), 2011.

* Vlãdãreanu AM, Popov V, Bumbea H, Ciufu C, Vasilache V, Petre A, Onisâi M, Pathogenesis of thrombotic and hemorrhagic complications in myeloproliferative and myelodysplastic syndromes, Rev Med Chir Soc Med Nat Iasi, Jan-Mar;115(1), 2011.

* Vlãdãreanu AM, Vasilache V, Bumbea H, Onisâi M., Platelet dysfunction in acute leukemias and myelodysplastic syndromes, Rom J Intern Med, 49(1), 2011.

* Bumbea H, Vladareanu AM, Vintilescu A, Radesi S, Ciufu C, Onisai M, Baluta C, Begu M, Dobrea C, Arama V, Streinu-Cercel A, Arama S, The lymphocyte immunophenotypical pattern in chronic lymphocytic leukemia associated with hepatitis viral infections, Journal of Medicine and Life, VOL. IV ISS 3, 2011.

* Mut-Popescu D, Lupu A, Bumbea H, Vladareanu AM, Barbu D, Angelescu S, Olteanu N, Colita A, Lymphoma immunophenotyping: "borderline" lymphomas, J Cell Mol Med, 4(3), 2000.

* Bumbea H, Serghei L, Vlãdãreanu AM, Stefan LM, Casleanu D, Voican I, Begu M, Cryptic genomic abnormalities associated with coexpression of KOR-SA3544 and NG.2 in proB acute lymphoblastic leukemia, Rom J Intern Med, 45(4), 2007.

* Abdulkadyrov K, Afanasiev B, Aguayo-Gonzalez A, Andre M, Belada D, Ben-Yehuda D, Bezares RF, Biakhov MY, Bolam S, Borbenyi Z, Bron D, Buckstein R, Bumbea H, Caballero Barrigon MD, Campos LT, Cantonetti M, Capra Zanella ME, Christiansen NP, Cohen GL, Colit, Bortezomib plus rituximab versus rituximab alone in patients with relapsed, rituximab-naive or rituximab-sensitive, follicular lymphoma: a randomised phase 3 trial, Lancet Oncology, 12(8), 2011.

* Béné MC, Nebe T, Bettelheim P, Buldini B, Bumbea H, Kern W, Lacombe F, Lemez P, Marinov I, Matutes E, Maynadié M, Oelschlagel U, Orfao A, Schabath R, Solenthaler M, Tschurtschenthaler G, Vladareanu AM, Zini G, Faure GC, Porwit A., Immunophenotyping of acute leukemia and lymphoproliferative disorders: a consensus proposal of the European LeukemiaNet Work Package 10, Leukemia, 25(4), 2011.

* Ana Maria Vladareanu, Carsten Müller-Tidow, Horia Bumbea, Sinziana Radesi, Molecular markers guide diagnosis and treatment in Philadelphia chromosome-negative myeloproliferative disorders (Review), Oncology Reports, Volume 23 Number 3, 2010.

* Rawstron, Andy C.; Orfao, Alberto; Beksac, Meral; Bezdickova, Ludmila; Broolmans, Rik A.; Bumbea, Horia; Dalva, Klara; Fuhler, Gwenny; Gratama, Jan; Hose, Dirk; Kovarova, Lucie; Lioznov, Michael; Mateo, Gema; Morilla, Ricardo; Mylin, Anne K.; Omede, Paol, Report of the European Myeloma Network on multiparametric flow cytometry in multiple myeloma and related disorders, HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 93 (3),, 2008.